FutureChem Co.,Ltd (KOSDAQ:220100)
8,130.00
+270.00 (3.44%)
Sep 4, 2026, 3:30 PM KST
FutureChem Co.,Ltd Revenue
FutureChem Co.,Ltd had revenue of 4.27B KRW in the quarter ending June 30, 2026, with 17.36% growth. This brings the company's revenue in the last twelve months to 20.59B, up 7.55% year-over-year. In the year 2025, FutureChem Co.,Ltd had annual revenue of 18.67B with 7.96% growth.
Revenue (ttm)
20.59B
Revenue Growth
+7.55%
P/S Ratio
8.85
Revenue / Employee
285.92M
Employees
n/a
Market Cap
182.29B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.67B | 1.38B | 7.96% |
| Dec 31, 2024 | 17.29B | 3.33B | 23.81% |
| Dec 31, 2023 | 13.97B | 1.39B | 11.09% |
| Dec 31, 2022 | 12.57B | 755.26M | 6.39% |
| Dec 31, 2021 | 11.82B | 805.07M | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chong Kun Dang Holdings | 961.64B |
| Daewon Pharmaceutical | 614.64B |
| Jeil Pharmaceutical Co.,Ltd | 543.49B |
| Ilyang Pharmaceutical Co.,Ltd | 277.96B |
| Whan In Pharm | 273.47B |
| JW Lifescience | 253.71B |
| Daihan Pharmaceutical | 216.55B |
| Yungjin Pharm. | 158.79B |